Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HINT1 | P49773 | 6/20 | 0.67 |
| ▸ | NT5E | P21589 | 1/20 | 0.67 |
| ▸ | GSK3A | P49840 | 2/20 | 0.62 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.62 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | TGM2 | P21980 | 1/20 | 0.61 |
| ▸ | PNP | P00491 | 1/20 | 0.60 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.58 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.58 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.58 |
| ▸ | KRAS | P01116 | 3/20 | 0.56 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL11084574 | 0.95 | HINT1 (0.67) | HINT1NT5EGSK3ARPS6KA3MAPK14 | |
| Guanosine SCHEMBL5550180 | 0.90 | HPGD (0.76) | HINT1NT5EGSK3ARPS6KA3MAPK14 | |
| Guanosine SCHEMBL20750695 | 0.90 | HPGD (0.76) | HINT1NT5EGSK3ARPS6KA3MAPK14 | |
| Guanosine SCHEMBL278157 | 0.90 | HPGD (0.76) | HINT1NT5EGSK3ARPS6KA3MAPK14 | |
| Guanosine SCHEMBL24049467 | 0.90 | HPGD (0.76) | HINT1NT5EGSK3ARPS6KA3MAPK14 | |
| Guanosine SCHEMBL24049417 | 0.90 | HPGD (0.76) | HINT1NT5EGSK3ARPS6KA3MAPK14 | |
| Guanosine SCHEMBL24049608 | 0.90 | HPGD (0.76) | HINT1NT5EGSK3ARPS6KA3MAPK14 | |
| Guanosine SCHEMBL24049416 | 0.90 | HPGD (0.76) | HINT1NT5EGSK3ARPS6KA3MAPK14 | |
| SCHEMBL16114035 | 0.90 | HINT1 (0.68) | HINT1NT5EGSK3ARPS6KA3MAPK14 | |
| Guanosine SCHEMBL7062800 | 0.90 | HPGD (0.76) | HINT1NT5EGSK3ARPS6KA3MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 914 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119866224-A | Polynucleotide encoding a linking antigen and uses thereof | 加拿大干细胞技术公司 | 2025-04-22 | — | — | CN | claimed |
| CN-119317430-A | Lipid nanoparticles comprising Venezuelan Equine Encephalitis (VEE) replicons and uses thereof | 斯特兰德生物科技公司 | 2025-01-14 | — | — | CN | claimed |
| WO-2024129779-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | MODERNATX, INC. (US) | 2024-06-20 | — | — | WO | claimed |
| WO-2023212618-A1 | LIPID NANOPARTICLES COMPRISING VENEZUELAN EQUINE ENCEPHALITIS (VEE) REPLICON AND USES THEREOF | STRAND THERAPEUTICS INC. (US) | 2023-11-02 | — | — | WO | claimed |
| CN-116916936-A | Compositions and methods for delivering RNA | 再生技术有限责任公司 | 2023-10-20 | — | — | CN | claimed |
| US-20230126310-A1 | COMPOSITIONS FOR CORONAVIRUS INFECTION TREATMENT AND/OR PREVENTION | FRAUNHOFER GES FORSCHUNG (DE) | 2023-04-27 | — | — | US | claimed |
| EP-4126234-A1 | COMPOSITIONS FOR CORONAVIRUS INFECTION TREATMENT AND/OR PREVENTION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-02-08 | — | — | EP | claimed |
| CN-115474430-A | Composition for treatment and/or prevention of coronavirus infection | 弗劳恩霍夫应用研究促进协会 | 2022-12-13 | — | — | CN | claimed |
| US-20220154222-A1 | NOVEL NUCLEIC ACID MODIFIERS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2022-05-19 | — | — | US | claimed |
| EP-3964206-A1 | COMPOUNDS FOR THE TREATMENT OF COVID-19 | Dompe' Farmaceutici S.P.A. (IT) | 2022-03-09 | — | — | EP | claimed |
| US-20110287412-A1 | Methods for Identifying RNA Segments Bound by RNA-Binding Proteins or Ribonucleoprotein Complexes | ROCKEFELLER UNIVERSITY (US) | 2011-11-24 | — | — | US | claimed |
| US-20100285001-A1 | Method and Compositions Related to Synergistic Responses to Oncogenic Mutations | UNIVERSITY OF ROCHESTER (US) | 2010-11-11 | — | — | US | claimed |
| EP-2188630-A2 | METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS | THE UNIVERSITY OF ROCHESTER (US) | 2010-05-26 | — | — | EP | claimed |
| WO-2010014636-A1 | METHODS FOR IDENTIFYING RNA SEGMENTS BOUND BY RNA-BINDING PROTEINS OR RIBONUCLEOPROTEIN COMPLEXES | ROCKEFELLER UNIVERSITY (US) | 2010-02-04 | — | — | WO | claimed |
| WO-2009045443-A2 | METHODS AND COMPOSITIONS RELATED TO SYNERGISTIC RESPONSES TO ONCOGENIC MUTATIONS | THE UNIVERSITY OF ROCHESTER (US) | 2009-04-09 | — | — | WO | claimed |
| US-20090042947-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS CONTAINING SULFUR | JON PTY LIMITED (AU) | 2009-02-12 | — | — | US | claimed |
| WO-2008125903-A2 | METHOD OF INHIBITING AN UNDESIRED IMMUNE RESPONSE | CHAIM SHEBA MEDICAL CENTER (US) | 2008-10-23 | — | — | WO | claimed |
| EP-1907407-A1 | IMPROVEMENTS TO ANALOGOUS COMPOUNDS OF 6-THIOGUANOSINE TRIPHOSPHATE, THEIR USE IN MEDICAL FIELDS AND PROCESSES FOR THEIR PREPARATION | Giuliani International Limited (IE) | 2008-04-09 | — | — | EP | claimed |
| WO-2007056817-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS CONTAINING SULFUR | JON PTY LIMITED (AU) | 2007-05-24 | — | — | WO | claimed |
| WO-2007010515-A1 | IMPROVEMENTS TO ANALOGOUS COMPOUNDS OF 6-THIOGUANOSINE TRIPHOSPHATE, THEIR USE IN MEDICAL FIELDS AND PROCESSES FOR THEIR PREPARATION | GIULIANI INTERNATIONAL LIMITED (IE) | 2007-01-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042947-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS CONTAINING SULFUR | SCLY, STS, SQOR | HINT1 1801/4885NT5E 4363/4885GSK3A 4508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.